-
Heavy First Imitation! Qilu Pharmaceutical's 'Aflibercept' Filed For Listing
On April 25, Qilu Pharmaceutical announced that the submitted application for marketing authorization of aflibercept intraocular injection solution wa...
2022-04-27 16:33 -
Sanofi Spins Off Oral Antipsychotic Drug Teralithe
Recently, the foreign biopharmaceutical website FiercePharma reported that Sanofi has transferred the rights of the antipsychotic drug Teralithe LP 40...
2022-04-27 16:30 -
Henlius Announces Second TIGIT Antibody Drug Application
On April 26, according to CDE's official website, Henlius' Class 1 new drug HLX53 was submitted for clinical application.
2022-04-27 16:27 -
We ECHEMI Pharmaceutical Hereby Notified That Our New Product Line EXCIPIENT Has Landed!
Pharmaceutical excipients belong to the pharmaceutical manufacturing fine-molecule industry, so the growth of the excipient market is positively corre...
2022-04-27 11:58 -
Pfizer Recalls Some Antihypertensive Drugs Due to Excessive Levels of Carcinogens
According to a report by Fox News on April 25, Pfizer announced a recall of five batches of its blood pressure drug Accupril after it was found to hav...
2022-04-26 18:12 -
Hengrui Medicine's Class 1 New Drugs Hit The 30 Billion Antithrombotic Drug Market
On April 25, Hengrui announced that its subsidiary Beijing Shengdi Pharmaceutical's class 1 new drug SHR-2004 injection was approved for clinical use
2022-04-26 18:09 -
Vivo Capital Co-founded! Xinrui Won Exclusive Rights to 4 RNAi Drugs in Greater China
On April 25, Arrowhead Pharmaceuticals announced that it had formed a joint venture with Vivo Capital, Visirna Therapeutics, which will be headquarter...
2022-04-26 18:02 -
What Is The Potential of NAMPT, A Target in The Tumor Field? Could It be The Next Hot Track?
Potential targets with clinical advantages are the targets that innovative drug R&D companies are looking for. However, in the face of today's global ...
2022-04-26 17:49 -
Roche's Q1 Performance Increases by 10%, And Total Revenue for the Year May Slow Down Due to COVID-1...
On April 25, Roche announced that the company's sales rose 10% in the first quarter.
2022-04-26 13:46 -
Biogen Withdraws European Marketing Application for New Alzheimer's Drug Aduhelm
On April 22, Biogen announced that it had notified the European Medicines Agency (EMA) of its decision to withdraw the Marketing Authorization Applica...
2022-04-25 16:43
Hot News
- ExxonMobil Launches $10 Billio... Jul 17, 2025
- Global MDI/TDI Plants Enter Pe... Jul 23, 2025
- Europe Faces Unprecedented Pet... Jul 23, 2025
- Guangdong Jieyang Puts into Op... Jul 16, 2025
- BASF Launches Second Round of ... Jul 24, 2025
Related Products
Related Producers
